Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.
about
Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methodsCircumventing antivector immunity: potential use of nonhuman adenoviral vectorsPre-existing vector immunity does not prevent replication deficient adenovirus from inducing efficient CD8 T-cell memory and recall responsesComplex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.Production of adenovirus vectors and their use as a delivery system for influenza vaccines.Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors.The influence of innate and pre-existing immunity on adenovirus therapyIdentification of sites in adenovirus hexon for foreign peptide incorporation.Outbreak of acute respiratory infection among infants in Lisbon, Portugal, caused by human adenovirus serotype 3 and a new 7/3 recombinant strain.Identification of the hexon region of an adenovirus involved in a new outbreak of keratoconjunctivitis.Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activationPhylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy.Modification of Ad5 hexon hypervariable regions circumvents pre-existing Ad5 neutralizing antibodies and induces protective immune responsesConstruction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon.Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines.Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus.Genetic characterisation of adenovirus type 8 isolated in Hiroshima city over a 15 year period.Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 HexonDevelopment of nonhuman adenoviruses as vaccine vectors.Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".Interaction between hexon and L4-100K determines virus rescue and growth of hexon-chimeric recombinant Ad5 vectorsEpidemic keratoconjunctivitis due to the novel hexon-chimeric-intermediate 22,37/H8 human adenovirusIdentification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.Improving adenovirus based gene transfer: strategies to accomplish immune evasion.Immune recognition of gene transfer vectors: focus on adenovirus as a paradigm.Tropism-modification strategies for targeted gene delivery using adenoviral vectors.Small-size recombinant adenoviral hexon protein fragments for the production of virus-type specific antibodies.Directed evolution of mutator adenoviruses resistant to antibody neutralization.Pseudopackaging of adenovirus type 5 genomes into capsids containing the hexon proteins of adenovirus serotypes B, D, or E.Replication-defective vector based on a chimpanzee adenovirus.Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys.Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera.Rescue of chimeric adenoviral vectors to expand the serotype repertoire.Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors.Isolation of a novel monkey adenovirus reveals a new phylogenetic clade in the evolutionary history of simian adenoviruses.Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration
P2860
Q24683349-152778C5-5AA7-4D03-8340-015156710F27Q26995655-42E981B9-9C08-4CEA-8991-463CACD6CF0CQ27304910-B86C3BF3-FE79-49BF-AD9E-31BEDAF23F2EQ27481420-36B82020-7972-4167-AB01-80A2139E871CQ30226988-DF77903B-A770-4582-AF62-7A9EAD13E29FQ33601808-70769F76-3196-47D1-9C7C-85F03E52C419Q33655401-D9E57101-C115-4EA6-9475-6B364F46CE9CQ33737591-EDDEA372-52F4-451A-8AC9-F9BA9E74CD46Q33769693-AFF06CE9-AA2A-4C23-B879-282FF146AA89Q33973214-E7E40146-72B6-4912-9D83-7697CD8C547DQ33987398-1CE6F1A5-25E7-4B09-A37A-0EA3570D6F22Q34228581-6151551D-7FDB-44A1-94BF-B369B6BF6CB7Q34229968-6D9F63F4-D094-4B1D-8638-605743CAB6AFQ34352485-37C803A6-EFAF-41E8-885A-7135C89411E8Q35182263-97DCA2D2-FA8B-4FF5-9C4B-DB3B6E1F6802Q35186597-C79791A0-178F-40ED-A774-34C107448DFBQ35586623-B6E654D1-13DE-42F8-8DB7-5F034BB00F4BQ36058021-A61658D8-700A-4729-BFB5-14ABD1421D97Q36317264-48C426E8-8441-4FA5-90A2-A1EF3D2C72BBQ36498186-A76481DD-B269-4F53-B6BF-8E61320503D6Q36645405-9DF5D1A3-77A2-4436-88E7-59B5723BE74FQ36933503-A453571A-DAD1-462C-9D3C-807E4393A82CQ37123522-45324B1F-15A7-4FD5-9B58-D5C8DE307B26Q37945219-CFCE0C14-2D46-4C97-A0A8-DB2EAC5BCF5FQ38008337-8F56F74B-6C4E-4BBB-B69F-4647245517C6Q38614156-57F0F69E-E8F7-4D2D-BBD1-B6B0DAB4A1D4Q38618197-6913B7B4-F940-4385-A361-7D6E84081E5CQ39181445-ABAC2C72-EBA0-476C-B9F4-0AFECE49A969Q39601057-F84F3DD8-2DF9-4571-AF64-715F7F7E5B14Q39605384-C0009A6B-B5E5-4C76-A286-C475E03EB663Q39612726-5D88F275-9345-4562-8C87-F535E1F4BC5FQ39683397-CCFD507B-6564-4905-98E5-EDFF1E96CDA4Q40188439-487C0378-2917-4410-BDAE-6DE7A8790195Q40624940-828C5082-FB8F-4637-9A0C-8258CC64549DQ41993648-4AFAAE1C-CEEA-425C-8EB6-13477B798212Q58770917-5FF6A7A3-CB8F-4D5E-986D-6C45AE86D9B6
P2860
Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Construction and characterizat ...... cation of adenovirus serotype.
@ast
Construction and characterizat ...... cation of adenovirus serotype.
@en
type
label
Construction and characterizat ...... cation of adenovirus serotype.
@ast
Construction and characterizat ...... cation of adenovirus serotype.
@en
prefLabel
Construction and characterizat ...... cation of adenovirus serotype.
@ast
Construction and characterizat ...... cation of adenovirus serotype.
@en
P2093
P2860
P1433
P1476
Construction and characterizat ...... ication of adenovirus serotype
@en
P2093
E Falck-Pedersen
R G Crystal
P2860
P304
10260-10264
P577
1998-12-01T00:00:00Z